FAQ

2-amino-3-chlorobutyric acid

Known as: TACB, alpha-amino-beta-chlorobutyrate, butanoic acid, 2-amino-3-chloro- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2012
01219892012

Related topics

Related topics

1 relation

Broader (1)

Aminobutyrates

Related mentions per year

Related mentions per year

1980-2013
19801990200020102020
2-amino-3-chlorobutyric acid
Aminobutyrates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
[Relationships between serum lipid composition and acetylator status as markers of energy metabolism in women with coronary heart disease, metabolic syndrome, and type 2 diabetes mellitus].
AIM To study relationships between the indicators of serum lipid composition (SLC) and the markers of acetylator (energy) status… (More)
Is this relevant?
2012
2012
Modulation of IL-10/IL-10R expression by mafosfamide, a derivative of 4-hydroxycyclophosphamide, in a rat B-cell lymphoma.
We have already shown that IL-10 plays an important role in immunosuppression and metastatic dissemination in the rat B-cell… (More)
  • figure 1
Is this relevant?
2010
2010
The immune response and the therapeutic effect of metronomic chemotherapy with cyclophosphamide.
Metronomic chemotherapy (MCT) is a novel therapeutic strategy for cancer treatment endowed with an antiangiogenic effect. It… (More)
  • figure 1
  • figure 2
Is this relevant?
2006
2006
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model
In recent years, one of the most important insights into tumor immunity was provided by the identification of negative regulatory… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2001
2001
Down regulation of T-cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response.
In previous reports, we demonstrated an inhibitory effect of a single low-dose of cyclophosphamide (Cy) on spontaneous and… (More)
Is this relevant?
2001
2001
The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression
We have demonstrated that a single low dose of cyclophosphamide has an antimetastatic effect on lymphoma (L-TACB)-bearing rats by… (More)
Is this relevant?
1999
1999
Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma
The HMGCoA reductase inhibitor Lovastatin (LOV) has previously shown to abrogate p21ras farnesylation, which is associated with… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
1998
1998
Modulation of the antimetastatic effect of a single low dose of cyclophosphamide on rat lymphoma.
The aim of this paper was to identify the mechanism/s responsible of the antimetastatic effect of a single low dose of… (More)
Is this relevant?
1990
1990
[Influence of host genotype in the development of metastasis in a transplantable lymphoma in rats].
For the purpose of investigating the influence of the host genotype in the metastatic process, the frequency of lymph nodes… (More)
Is this relevant?
1989
1989
[Inheritance of susceptibility to tumors and metastases in rodents].
The behavior of two spontaneous transplantable rat tumors and a mouse lymphoma was studied in different hosts. A resistant (eR… (More)
Is this relevant?